Aquatic Capital Management LLC Biotechnology

Aquatic Capital Management LLC

$3.57 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ASND Ascendis Pharma A/S	$8.74B	$230,000 0.01% of portfolio	1,674	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$177M	$184,000 0.01% of portfolio	31,565	Q4 2024 New
TSHA Taysha Gene Therapies, Inc.	$77.4M	$135,000 0.0% of portfolio	78,246	Q4 2024 New
CLDX Celldex Therapeutics, Inc.	$962M	$120,000 0.0% of portfolio	4,780	Q4 2024 New
GMAB Genmab A/S	$14.9B	$113,000 0.0% of portfolio	5,459	Q4 2024 New
URGN Uro Gen Pharma Ltd.	$215M	$100,000 0.0% of portfolio	9,446	Q4 2024 New
IMNM Immunome Inc.	$114M	$91,000 0.0% of portfolio	8,935	Q4 2024 New
NRIX Nurix Therapeutics, Inc.	$728M	$86,000 0.0% of portfolio	4,610	Q4 2024 New
NUVB Nuvation Bio Inc.	$428M	$83,000 0.0% of portfolio	31,431	Q4 2024 New
CGEM Cullinan Oncology, Inc.	$387M	$77,000 0.0% of portfolio	6,357	Q4 2024 New
EWTX Edgewise Therapeutics, Inc.	$1.65B	$77,000 0.0% of portfolio	2,894	Q4 2024 New
AXSM Axsome Therapeutics, Inc.	$5.47B	$76,000 0.0% of portfolio	903	Q4 2024 New
LGND Ligand Pharmaceuticals Inc	$2.06B	$75,000 0.0% of portfolio	703	Q4 2024 Reduced 21.89%
PLRX Pliant Therapeutics, Inc.	$167M	$73,000 0.0% of portfolio	5,596	Q4 2024 Added 1,299.0%
LRMR Larimar Therapeutics, Inc.	$131M	$69,000 0.0% of portfolio	18,160	Q4 2024 New
TYRA Tyra Biosciences, Inc.	$492M	$63,000 0.0% of portfolio	4,586	Q4 2024 New
CELC Celcuity Inc.	$141M	$50,000 0.0% of portfolio	3,840	Q4 2024 New
XERS Xeris Biopharma Holdings, Inc.	$521M	$49,000 0.0% of portfolio	14,684	Q4 2024 New
AKBA Akebia Therapeutics, Inc.	$340M	$46,000 0.0% of portfolio	24,998	Q4 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$280M	$43,000 0.0% of portfolio	5,188	Q4 2024 New
IMCR Immunocore Holdings PLC	$1.29B	$41,000 0.0% of portfolio	1,400	Q4 2024 Reduced 87.16%
TBPH Theravance Biopharma, Inc.	$624M	$24,000 0.0% of portfolio	2,604	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$161M	$20,000 0.0% of portfolio	3,510	Q4 2024 Reduced 12.25%
MRSN Mersana Therapeutics, Inc.	$50.5M	$20,000 0.0% of portfolio	14,551	Q4 2024 New
YMAB Y M Abs Therapeutics, Inc.	$243M	$19,000 0.0% of portfolio	2,520	Q4 2024 New
AGIO Agios Pharmaceuticals, Inc.	$1.95B	$17,000 0.0% of portfolio	529	Q4 2024 New
KMPH Kempharm, Inc	$170M	$8,000 0.0% of portfolio	1,643	Q4 2024 New
HUMA Humacyte, Inc.	$350M	$7,000 0.0% of portfolio	1,579	Q4 2024 Reduced 92.82%
ADMA Adma Biologics, Inc.	$3.22B	$0 0.0% of portfolio	27	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.